Replies to post #819270 on NorthWest Biotherapeutics Inc (NWBO)

[Tom33777]

Yep, that’s it. Thanks. And it is 70 pages

[beachhyena]

I would take this research document with a pinch of salt as much of it could have been gleaned from the hundreds of pages of research already done by many. What is important that the magical $1.00 valuation is the exact amount the shorts have been pushing as the maximum price on approval for a very long time. With 1.4 billion this article no doubt sponsored by the short crowds HF and MM friends is being put in place to try and control the price escalation after NWBO approval. They are hoping that longs will sell on masse at $1.00. What a joke this article is and Herr Gaurav Tiwari needs to be looked at closely for putting out such a low valuation.

[NotSure2]

Did they hired Dstock/Danish Dude to write this part? See ->

followed by pricing and
reimbursement negotiations with NICE through 2026 and early 2027, and a
first commercial launch in the UK later in 2027

NICE reimbursement negotiations will easily take 2-3 years from MHRA decision. Not 1 year or less.

first commercial launch in the UK later in 2027... (read 2028 for real life) but lets say it is late 2027, well this mean there is another year of dilution minimum. And without NICE reimbursment, well another 2-3 years...

Hopefully this overly optimistic report open the eyes of many. We all got scammed. By the likes of friends/acquintances who believed idiot/scam artist like (we all know their usernames).